Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Recruiting · NCT04008121 · Registry updated 2026-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium | Diabetes Complications, Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Recruiting | Early phase 1 | 2026-02-04 | NCT04008121 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MediBeacon | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Michigan Kellogg Eye Center | Ann Arbor | United States | 9 |